News

Newk's Unites 100 Restaurants to Raise $100,000 for Ov...

Newk's Unites 100 Restaurants to Raise $100,000 for Ovarian Cancer Research

May 20, 2016

Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss. — Pairing a big moment with a big cause, fast-casual Newk’s Eatery is celebrating its centennial restaurant opening by uniting system-wide to raise $100,000 for ovarian cancer research starting April 4. Each of Newk’s 100 restaurants has committed to raising $1,000, inviting … Continued

Community

Newk's Raises more than $110,000 for OCRFA

Newk's Raises more than $110,000 for OCRFA

May 20, 2016

When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis. Blindsided and heartbroken by a type of cancer very few recognize or understand, Lori and her husband Chris, Co-founder and CEO of Newk’s Eatery, saw an opportunity to save women’s … Continued

Community

Zubik v. Burwell & the Supreme Court

Zubik v. Burwell & the Supreme Court

May 17, 2016

FOR IMMEDIATE RELEASE May 17, 2016   Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v. Burwell to Lower Courts to Resolve Access to Cost-Free Contraceptive Services to Women “We urge the lower courts to move quickly and to consider the impact of their decision on the future of women’s preventative healthcare, especially as a … Continued

Advocacy

Webinar: Clinical Trials: What you need to know

Webinar: Clinical Trials: What you need to know

May 9, 2016

Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer patients. Dr. Dorigo discussed what clinical trials are, why they are important and how they work, the pros and cons of enrolling … Continued

Information

Long Term Survival Study Recruiting Participants

Long Term Survival Study Recruiting Participants

May 9, 2016

The Consortium for Long-Term Survival — is bringing together research groups worldwide. These groups include survivors, patient advocates and advocacy groups, (not just researchers) with the goal of “FINDING THE KEY TO LONG-TERM SURVIVAL FOR ALL WOMEN.” RECRUITING NOW: 8+ year survivors, STAGE 3 or 4 ONLY, contact Giulia Fulci, gfulci@partners.org or 617-643-7261. View more … Continued

Research

OCRFA Research Helps Explain Resistance to Chemotherapy

OCRFA Research Helps Explain Resistance to Chemotherapy

May 4, 2016

(May 4, 2016) Research funded in part by an OCRFA research grant to Dr. Weiping Zou at the University of Michigan has shown that the sensitivity and resistance to cancer chemotherapies is not fully explained by genomic mechanisms as it has previously thought.  In fact, it may be affected by effector T cells (cells that defend … Continued

OCRA News

OVARYact

May 3, 2016

Lauren Richards lost her mom Rochelle Richards to ovarian cancer earlier this year. Lauren set out on a mission to make a difference in her community and to honor her mom’s journey. On April 22nd, Lauren hosted a benefit concert called “OVARYact” at Will’s Pub in Orlando, FL. The concert had an admission fee of … Continued

Community

The Vicki Welsh Fund

May 3, 2016

The Vicki Welsh Fund for Ovarian Cancer began 10 years ago, with the goal of fighting ovarian cancer through awareness, education, research, and support. At the heart of the organization is Vicki Welsh, an outgoing and compassionate woman who lost her battle to ovarian cancer in 2006. Sadly, Vicki’s mother-in-law lost her own battle to … Continued

Community

Irregular Periods May Increase Ovarian Cancer Risk

Irregular Periods May Increase Ovarian Cancer Risk

May 2, 2016

(May 2, 2016) Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life. The study provides the first evidence linking abnormally long cycles or missed periods to higher ovarian cancer risk. It … Continued

Research

Stand Up To Cancer Supports “Innovation in Collaboration” i...

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards

May 2, 2016

May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-­‐affiliated scientists. Each team, consisting of researchers from different SU2C-­‐supported “Dream Teams” or research programs, will receive a grant of $200,000 to support new research projects stemming … Continued

OCRA News

Stand Up To Cancer Supports “Innovation in Collaboration” i...

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research

May 2, 2016

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-affiliated scientists. Each team, consisting … Continued

OCRA News

Hormone Therapy Safe After Nonserous Ovarian Cancer

Hormone Therapy Safe After Nonserous Ovarian Cancer

April 25, 2016

(April 25, 2016) New findings published online this month in Obstetrics and Gynecology suggest that hormone therapy (HT) can be used safely to manage menopausal symptoms in women who have undergone treatment for nonserous epithelial ovarian cancer. The study showed no reduction in overall survival with HT use in the entire study population, and it … Continued

Research